Stox
20
Bajaj Healthcare Limited
NSE: BAJAJHCARE · Unclassified
₹310.70-2.92%06 Nov 2026
Ask the data
Instant answers about Bajaj Healthcare Limited — computed from its filings, no language modelMarket cap₹1,046 cr
Current price₹310.70
High / Low₹481 / ₹275
P/E50.7
P/B1.88
Book value₹165.5
ROE3.7%
ROCE6.9%
Debt / equity0.48
Dividend yield0.30%
EPS (TTM)₹6.12
Face value₹5
Price & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY20† | FY21† | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | 410.0 | 657.0 | 679.9 | 673.3 | 473.4 | 542.6 | 611.0 |
| EBITDA | 47.5 | 136.3 | 118.5 | 106.8 | 76.3 | 82.4 | 104.8 |
| Operating margin | 11.6% | 20.8% | 17.4% | 15.9% | 16.1% | 15.2% | 17.2% |
| Interest | 6.4 | 8.3 | 12.6 | 22.9 | 29.7 | 27.9 | 22.2 |
| Depreciation | 12.1 | 16.1 | 17.6 | 27.4 | 27.6 | 27.9 | 27.6 |
| Profit before tax | 32.5 | 118.8 | 89.7 | 58.2 | -16.7 | 46.0 | 28.9 |
| Tax | 9.9 | 35.7 | 18.3 | 15.2 | -2.4 | 3.1 | 7.6 |
| Net profit | 22.5 | 83.1 | 71.4 | 43.0 | -83.8 | 39.5 | 15.8 |
| EPS ₹ | — | — | 25.87 | 15.59 | -30.36 | 13.29 | 4.98 |
| Operating cash flow | — | — | 0.7 | -22.3 | 92.3 | 21.6 | 58.1 |
| Capex | — | — | 74.2 | 93.6 | 30.3 | 11.5 | 43.4 |
| Dividend paid | — | — | 1.4 | 4.1 | 2.8 | 2.8 | 3.2 |
| Total assets | — | — | — | 901.5 | 765.1 | 833.0 | 923.2 |
| Equity | — | — | — | 367.7 | 278.4 | 466.2 | 533.0 |
Quarterly performance
last 30 quarters · ₹ crore| JUN '19† | SEP '19† | DEC '19† | MAR '20† | JUN '20† | SEP '20† | DEC '20† | MAR '21† | JUN '21† | SEP '21† | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22† | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 91.7 | 100.5 | 99.3 | 118.5 | 139.8 | 206.6 | 178.3 | 132.2 | 185.7 | 150.9 | 167.6 | 175.7 | 172.1 | 200.9 | 141.9 | 158.4 | 129.7 | 101.2 | 108.6 | 133.9 | 132.2 | 133.1 | 122.8 | 154.5 | 148.8 | 147.9 | 161.2 | 153.1 | 165.6 | 175.9 |
| Operating profit | 9.0 | 9.0 | 13.6 | 15.9 | 25.4 | 32.3 | 44.0 | 34.6 | 33.5 | 29.0 | 30.8 | 25.2 | 25.8 | 33.3 | 28.6 | 19.1 | 21.7 | 18.9 | 19.5 | 16.0 | 24.5 | 24.5 | 21.6 | 11.8 | 24.5 | 26.9 | 30.7 | 22.7 | 28.8 | 31.2 |
| Operating margin | 9.8% | 9.0% | 13.7% | 13.4% | 18.1% | 15.6% | 24.7% | 26.2% | 18.0% | 19.2% | 18.4% | 14.3% | 15.0% | 16.6% | 20.2% | 12.0% | 16.8% | 18.7% | 18.0% | 12.0% | 18.5% | 18.4% | 17.6% | 7.6% | 16.5% | 18.2% | 19.0% | 14.8% | 17.4% | 17.7% |
| Other income | 0.4 | 0.1 | 0.1 | 2.9 | 0.9 | 2.1 | 1.8 | 2.1 | 0.7 | 0.1 | 0.2 | 0.5 | 0.7 | 0.1 | 0.1 | 0.7 | 0.2 | 1.2 | 0.8 | 6.5 | 0.8 | 2.6 | 2.4 | 13.6 | 0.9 | 1.6 | 1.6 | 3.0 | 0.8 | 0.9 |
| Interest | 1.8 | 1.6 | 1.6 | 1.4 | 2.0 | 2.2 | 1.9 | 2.1 | 2.8 | 2.5 | 2.8 | 4.5 | 3.8 | 5.0 | 6.7 | 7.4 | 8.8 | 8.3 | 6.7 | 6.0 | 8.4 | 7.9 | 5.5 | 6.1 | 5.2 | 5.6 | 5.9 | 5.6 | 6.1 | 6.0 |
| Depreciation | 2.9 | 3.0 | 2.9 | 3.4 | 3.8 | 4.0 | 4.0 | 4.4 | 4.1 | 4.4 | 4.9 | 4.2 | 6.5 | 6.5 | 6.9 | 7.4 | 6.3 | 6.7 | 7.3 | 7.3 | 6.7 | 6.8 | 6.8 | 7.5 | 5.6 | 7.1 | 7.2 | 7.6 | 7.0 | 7.7 |
| Profit before tax | 4.6 | 4.6 | 9.2 | 14.0 | 20.4 | 28.3 | 39.9 | 30.2 | 27.2 | 22.2 | 23.3 | 16.9 | 16.2 | 22.0 | 15.0 | 5.0 | 6.9 | 5.2 | 6.3 | -35.1 | 10.2 | 12.4 | 11.7 | 11.7 | 14.5 | 16.0 | 19.2 | -20.8 | 16.5 | 18.5 |
| Tax | 1.4 | 1.3 | 2.9 | 4.4 | 5.1 | 8.1 | 13.5 | 8.9 | 8.0 | 4.9 | 5.9 | -0.5 | 4.1 | 5.7 | 4.0 | 1.4 | -0.1 | 0.1 | 0.8 | -3.1 | 2.2 | 4.1 | -3.3 | 0.1 | 2.4 | 3.5 | 3.1 | -1.4 | 2.6 | 4.1 |
| Net profit | 3.2 | 3.3 | 6.4 | 9.6 | 15.3 | 20.1 | 26.4 | 21.3 | 19.2 | 17.2 | 17.4 | 17.5 | 12.0 | 16.4 | 11.1 | 3.6 | -48.2 | -3.5 | -2.2 | -29.9 | 7.1 | 9.5 | 11.7 | 11.2 | 11.8 | 11.1 | 15.7 | -22.9 | 13.7 | 14.1 |
| EPS ₹ | 2.35 | 2.38 | 4.62 | 6.96 | 11.08 | 14.58 | 19.15 | 15.42 | 13.93 | 6.25 | 6.32 | 6.33 | 4.35 | 5.93 | 4.01 | 1.30 | -17.46 | -1.25 | -0.80 | -10.84 | 2.59 | 3.36 | 3.65 | 3.54 | 3.74 | 3.53 | 4.96 | -7.16 | 4.07 | 4.19 |
| Revenue YoY | — | — | — | — | 52.5% | 105.5% | 79.6% | 11.5% | 32.8% | -27.0% | -6.0% | 32.9% | -7.3% | 33.1% | -15.3% | -9.8% | -24.6% | -49.6% | -23.5% | -15.5% | 1.9% | 31.5% | 13.1% | 15.4% | 12.5% | 11.1% | 31.3% | -0.9% | 11.3% | 18.9% |
| Profit YoY | — | — | — | — | 371.9% | 513.4% | 314.1% | 121.7% | 25.7% | -14.3% | -34.0% | -17.9% | -37.5% | -5.2% | -36.7% | -79.5% | -501.1% | -121.1% | -119.9% | -933.4% | — | — | — | — | 65.9% | 17.4% | 33.7% | -304.4% | 15.8% | 26.8% |
Returns & margins
trailing-twelve-month, per quarter| MAR '20 | JUN '20 | SEP '20 | DEC '20 | MAR '21 | JUN '21 | SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | 17.7% | 15.9% | 11.7% | -4.7% | -11.7% | -15.9% | -30.1% | -10.2% | -3.5% | -0.4% | 8.5% | 9.5% | 9.4% | 10.2% | 3.0% | 3.3% | 3.7% |
| ROCE | — | — | — | — | — | — | — | — | — | — | 13.7% | 13.0% | 10.4% | 9.8% | 9.4% | 8.1% | 2.1% | 2.6% | 3.5% | 4.1% | 10.7% | 10.9% | 10.8% | 11.9% | 6.7% | 7.0% | 6.9% |
| Net margin | 5.5% | 7.5% | 9.1% | 11.1% | 12.7% | 12.4% | 13.0% | 11.8% | 10.5% | 9.6% | 8.8% | 8.2% | 6.4% | -2.7% | -7.0% | -10.1% | -17.7% | -6.0% | -3.1% | -0.3% | 7.3% | 7.9% | 8.0% | 8.1% | 2.6% | 2.8% | 3.1% |
| EBITDA margin | 11.6% | 13.9% | 15.5% | 18.3% | 20.8% | 20.6% | 21.8% | 20.1% | 17.4% | 16.6% | 16.1% | 16.4% | 15.9% | 16.3% | 16.6% | 15.9% | 16.1% | 16.6% | 16.7% | 16.6% | 15.2% | 14.7% | 14.8% | 15.3% | 17.2% | 17.4% | 17.3% |
| Debt / equity | — | — | — | — | — | — | — | — | — | — | 0.94 | 0.94 | 1.13 | 1.13 | 1.13 | 1.13 | 1.19 | 1.19 | 0.46 | 0.46 | 0.48 | 0.48 | 0.45 | 0.45 | 0.44 | 0.44 | 0.48 |
| Interest coverage | 6.04 | 8.25 | 10.91 | 14.63 | 15.33 | 14.91 | 13.77 | 11.01 | 8.11 | 6.76 | 5.87 | 4.51 | 3.55 | 2.76 | 2.03 | 1.76 | 0.44 | 0.54 | 0.79 | 0.97 | 2.65 | 3.04 | 3.41 | 3.70 | 2.30 | 2.34 | 2.42 |
| Asset turnover | — | — | — | — | — | — | — | — | — | — | 0.87 | 0.84 | 0.75 | 0.70 | 0.63 | 0.59 | 0.62 | 0.62 | 0.63 | 0.65 | 0.65 | 0.67 | 0.68 | 0.73 | 0.66 | 0.68 | 0.67 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '22 | MAR '23 | SEP '23 | MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Share capital | 13.8 | 13.8 | 13.8 | 13.8 | 15.8 | 15.8 | 15.8 | 16.8 | 16.8 |
| Other equity / reserves | 343.1 | 353.9 | 302.4 | 264.6 | 430.0 | 450.4 | 470.6 | 516.2 | 540.3 |
| Total equity | 356.9 | 367.7 | 316.1 | 278.4 | 445.8 | 466.2 | 486.4 | 533.0 | 557.2 |
| Borrowings | 334.5 | 414.3 | 356.1 | 332.1 | 205.1 | 222.6 | 221.2 | 233.5 | 267.5 |
| Current liabilities | 399.6 | 436.1 | 412.6 | 375.6 | 288.0 | 272.3 | 269.8 | 319.6 | 324.4 |
| Non-current liabilities | 69.1 | 97.7 | 61.0 | 71.7 | 37.9 | 69.9 | 67.2 | 57.7 | 89.4 |
| Total assets | 825.6 | 901.5 | 837.9 | 765.1 | 804.0 | 833.0 | 838.9 | 923.2 | 981.1 |
| Property, plant & equipment | 262.1 | 365.7 | 243.1 | 252.1 | 238.0 | 236.6 | 215.3 | 247.2 | 228.4 |
| Capital work-in-progress | 93.1 | 21.7 | 13.9 | 4.8 | 9.7 | 3.5 | 5.8 | 7.9 | 10.7 |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventories | 183.1 | 208.8 | 202.8 | 144.0 | 142.4 | 161.9 | 156.3 | 216.0 | 236.5 |
| Receivables | 223.7 | 227.4 | 219.9 | 180.2 | 216.9 | 251.7 | 231.9 | 233.8 | 251.6 |
| Cash & equivalents | 13.5 | 17.7 | 5.5 | 2.2 | 21.5 | 2.6 | 12.0 | 37.2 | 13.5 |
Cash flow
annual · ₹ crore · line = free cash flow| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 0.7 | -22.3 | 92.3 | 21.6 | 58.1 |
| Cash from investing | -74.8 | -93.4 | -11.2 | -14.8 | -47.8 |
| Cash from financing | 61.9 | 131.5 | -96.6 | -6.4 | 24.3 |
| Capex | 74.2 | 93.6 | 30.3 | 11.5 | 43.4 |
| Free cash flow | -73.5 | -115.9 | 62.0 | 10.1 | 14.7 |
| Dividends paid | 1.4 | 4.1 | 2.8 | 2.8 | 3.2 |
Where the assets sit
Sep '26 · ₹ croreFixed assets (PPE)₹228.4 cr23%
CWIP₹10.7 cr1%
Investments₹0.0 cr0%
Inventories₹236.5 cr24%
Receivables₹251.6 cr26%
Cash & equivalents₹13.5 cr1%
Other assets₹240.5 cr25%
Peer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Bajaj Healthcare Limited | 1,046 | 310.70 | 50.7 | 1.88 | 3.7% |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
1 month-3.9%
6 months-8.5%
1 year-32.3%
3Y CAGR-9.2%
5Y CAGR—
10Y CAGR—
50-day avg₹325.83
200-day avg₹327.53
RSI (14)29
FAQs
What is the share price of Bajaj Healthcare Limited?
Bajaj Healthcare Limited (BAJAJHCARE) closed at ₹310.70 on NSE on 06 Nov 2026.
What is the market cap of Bajaj Healthcare Limited?
₹1,046 crore at the latest close.
What is the P/E ratio of Bajaj Healthcare Limited?
50.7, on trailing-twelve-month earnings from its filings.
How fast is Bajaj Healthcare Limited growing?
Bajaj Healthcare Limited: revenue has compounded at -3.2% a year over three years; net profit at -28.4% a year. Latest-quarter revenue is up 18.9% year on year, profit up 26.8%.
How profitable is Bajaj Healthcare Limited?
On a trailing-twelve-month basis return on equity is 3.7%, return on capital employed 6.9%, operating margin 17.3%, net margin 3.1%.
How much debt does Bajaj Healthcare Limited have?
Bajaj Healthcare Limited is lightly geared: debt to equity is 0.48 with borrowings of ₹268 cr against cash of ₹13 cr (balance sheet of 2026-09-30). Operating profit covers interest 2.4 times.
Financials parsed from Bajaj Healthcare Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before DEC '21 and quarters missing from the NSE filings (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.
Bajaj Healthcare Limited · advanced chart